SURMAX 200 PREMIX DIN 02436760
Status: Cancelled Post Market
Holder: ELANCO CANADA LIMITED
Health Canada record
| Active ingredient(s) | AVILAMYCIN 200 G |
|---|
| Dosage form | Drug Premix |
|---|
| Route | Oral |
|---|
| Schedule | PRESCRIPTION |
|---|
| Class | Veterinary |
|---|
| ATC | |
|---|
| Original market date | 22-Mar-2016 |
|---|
| Current status date | 01-Dec-2019 |
|---|
| Source | Health Canada DPD |
|---|
Establishment licence of the holder
Elanco Canada Limited — licence 102236, currently licensed, last inspection rating C (2022-08-03).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing AVILAMYCIN
| DIN | Product | Company | Form | Strength | Status |
|---|
| 02421062 | SURMAX PREMIX | ELANCO CANADA LIMITED | Drug Premix | AVILAMYCIN 100 G | Marketed |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|
| 20431 | 2018-02-02 | New Drug Submission (NDS) | MERGER - BUYOUT |
| 16570 | 2015-01-29 | New Drug Submission (NDS) | |
Request a quote for SURMAX 200 PREMIX
How to read a Canadian DIN record